ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,645.81
      0.26%
      US Tech 100
      19,780.80
      -0.33%
      Dow Jones
      40,769.69
      1.39%
      Brent Oil
      83.45
      -1.06%
      Bitcoin
      64,388.02
      -0.71%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Repare Therapeutics Inc (RPTX) Quote

      Repare Therapeutics Inc

      Repare Therapeutics Inc (RPTX)

      NASDAQ
      3.9001
      0.3001
      ( 8.34% )
      Updated: 13:14:19
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      3.9001
      Bid
      3.89
      Ask
      3.94
      Volume
      149,501
      3.62 Day's Range 4.00
      2.98 52 Week Range 13.85
      Market Cap
      152.803M
      Previous Close
      3.60
      Open
      3.62
      Last Trade
      47
      @
      3.91
      Last Trade Time
      13:14:17
      Financial Volume
      $ 572,450
      VWAP
      3.8291
      Average Volume (3m)
      265,210
      Shares Outstanding
      42,445,406
      Dividend Yield
      -
      PE Ratio
      -1.74
      Earnings Per Share (EPS)
      -2.21
      Revenue
      51.13M
      Net Profit
      -93.8M

      About Repare Therapeutics Inc

      Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability,... Repare Therapeutics Inc is a precision oncology company engaged in the discovery and development of novel therapeutics. The company use its proprietary, genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Using its SNIPRx platform, it is developing pipeline of SL product candidates, including its product candidate, RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.reparerx.com
      Headquarters
      Saint-laurent, Quebec, Can
      Founded
      1970
      Repare Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPTX. The last closing price for Repare Therapeutics was $3.60. Over the last year, Repare Therapeutics shares have traded in a share price range of $ 2.98 to $ 13.85.

      Repare Therapeutics currently has 42,445,406 shares outstanding. The market capitalization of Repare Therapeutics is $152.80 million. Repare Therapeutics has a price to earnings ratio (PE ratio) of -1.74.

      RPTX Latest News

      More News

      Alberta Enterprise Corporation invests US$7.5 million into Amplitude precision medicine fund

      Alberta Enterprise Corporation invests US$7.5 million into Amplitude precision medicine fund Canada NewsWire EDMONTON, AB, July 16, 2024 AEC invests US$7.5M into Amplitude Ventures US$192M Fund...

      4 hours ago
      PR Newswire (Canada)

      Repare Therapeutics Announces Positive Initial Data at ESMO GI from Phase 1 MINOTAUR Trial Evaluating Lunresertib in Combination with FOLFIRI

      Overall response of 18.2% in heavily pretreated patients across gastrointestinal tumors with target alterations regardless of prior irinotecan exposure Prolonged clinical benefit in patients with...

      June 26 2024
      Business Wire

      Form 8-K - Current report

      June 17 2024
      Edgar (US Regulatory)

      Repare Therapeutics Doses First Patient in Camonsertib Monotherapy Non-Small Cell Lung Cancer Expansion of TRESR Clinical Trial

      Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the first patient has been dosed in the Company’s...

      June 10 2024
      Business Wire

      Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer

      Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has granted...

      June 04 2024
      Business Wire

      Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

      Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will...

      June 03 2024
      Business Wire

      Repare Therapeutics to Present Initial Phase 1 MINOTAUR Data at ESMO GI Congress 2024

      Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, announced initial data from the Phase 1 MINOTAUR study evaluating...

      May 29 2024
      Business Wire

      Form S-8 - Securities to be offered to employees in employee benefit plans

      May 24 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 07 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.680121.12111801243.2243.211855933.53242294CS
      40.04011.038860103633.8643.091603923.44807722CS
      120.660120.37345679013.244.133.032652103.60118783CS
      26-2.7099-40.99697428146.618.492.981905544.48215789CS
      52-7.0499-64.382648401810.9513.852.982234975.55419864CS
      156-25.4199-86.698158253829.3235.752.9823922712.2077274CS
      260-28.1499-87.83120124832.0546.442.9821207315.53946402CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SILOSilo Pharma Inc
      $ 2.0907
      (95.39%)
      		132.17M
      TKLFYoshitsu Company Ltd
      $ 0.5839
      (90.66%)
      		273.48M
      NAASNaaS Technology Inc
      $ 4.26
      (52.14%)
      		15.87M
      VRPXVirpax Pharmaceuticals Inc
      $ 1.47
      (37.38%)
      		11.13M
      WKHSWorkhorse Group Inc
      $ 2.1494
      (30.27%)
      		3.58M
      CYNCYNGN Inc
      $ 6.91
      (-24.73%)
      		784.57k
      AMIXAutonomix Medical Inc
      $ 1.08
      (-21.74%)
      		5.47M
      NBSTWNewbury Street Acquisition Corporation
      $ 0.090295
      (-18.43%)
      		120
      AEHLAntelope Enterprise Holdings Ltd
      $ 4.2488
      (-17.82%)
      		373.37k
      CMNDClearmind Medicine Inc
      $ 1.84
      (-17.12%)
      		1.96M
      TKLFYoshitsu Company Ltd
      $ 0.5839
      (90.66%)
      		273.48M
      SILOSilo Pharma Inc
      $ 2.095
      (95.79%)
      		132.17M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.25995
      (14.52%)
      		131.79M
      NVDANVIDIA Corporation
      $ 125.78
      (-2.07%)
      		129.83M
      CDTConduit Pharmaceuticals Inc
      $ 0.302701
      (26.13%)
      		92.92M

      RPTX Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      RPTX under $5
      👍️0
      Monksdream Monksdream 11 months ago
      From that awful Cathie Wood
      Repare Therapeutics (RPTX)
      icon-rise-1
      17%
      Shares of Repare Therapeutics traded up ~17% on Thursday after the company announced10 its second-quarter financial results. During its Research and Development Day in the fourth quarter, management will present updates on the company’s preclinical pipeline and disclose the target for RP-1664. Repare Therapeutics is a precision oncology company searching for novel therapeutics targets by using its discovery platform, SNIPRX.
      👍️0
      Gator44 Gator44 2 years ago
      I believe we going to break 15 on today is close.
      👍️0
      ElusTrade ElusTrade 2 years ago
      I believe we going hit 15 this week if not more....
      👍️0
      akamaii akamaii 2 years ago
      Not alone bought on the news sold Friday 1290 flipped twice and long now again till 20 May flip along the way 15 next the deal is good stuff and the stock is down roche just put a seal of approval
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: We just busted-through to a "LUCKY THIRTEEN DOLLARS" price!!! NOT quite to the MOON, as they say. But what-the-FLICK, I'll take it!!

      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Something is UP!!!! INDEED, a shinny-new GREEN COLOR for our --- well, at least MY shares --- of RPTX!! RPTX just might have some UPDATE NEWS coming next Monday, Peeps!! (HA-HA-HA!!!)

      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: GREEN!!!! Green is beautiful!!! "GREEN-STOCKS-MATTER"!!!!!




      "And by the way, iHub, I don't give a FLUCK if Morgan Fairchild just turned Sweet-116-Years old!!!!"
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Oooooops!!! You MM's can NOT keep our little GREEN-PRICE-Parrot away forever!!! So cut-that-out, you reprobate MM's!!!!

      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: I just LOVE being ALONE over here!! (However, click handy LINK, below, for the "Bee Gees" EPIC ballad with THAT name!!! Maybe the BEST "ballad" ever done!!! Yet I'll wager that NOBODY here as ever even HEARD about this song!!! HA-HA-HA!!!)



      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Well, good morning, FOLKS!!! (Just trying to get a word in here edgewise is difficult, as you can see! We 'gots' so many POSTS here everyday, the iHub Algorithms simply can't handle the action!! )

      In any event, GO-GO-GO-RPTX!!! Take us to the MOON today!! Well, at least maybe to the 'International SPACE STATION??? (HA-HA-HA!!!)

      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: NOT a bad day here.
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Hey, 'RA-40' Dude, your post is the BEST point of the DAY about this RPTX-Roche-Company partnership!! Indeed, THAT many SHARES traded at the circa $9-$12 price range is impressive. This Company has nice, BIG, upside PRICE potential. Big-Time-ROCHE didn't cement that HUGE deal today because RPTX is some Stinky-Pinky-Wanna-Be-Big-PHARMA, with scores of USELESS "Patents-Pending"; nor weekly (Elementary School) Petri-Dish-&-Test-Tube-Studies; nor Miraculous-Sick-MICE-Cures!

      See-ya tomorrow!!!

      👍️0
      retireat40 retireat40 2 years ago
      No one noticing? Volume was 139 times normal
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: May have a late-day RUN here, Folks!! Whether anyone likes it, or not!!! (HA-HA-HA!!!)


      "Heck, ya never know WHAT-THE-FLUCK is gonna happen on these Stock Market GAMBLING CASINOS these days!!!!"
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: They WILL notice this little GEM, Dude --- soon enough!!!

      https://www.fool.com/investing/2022/06/02/why-repare-therapeutics-stock-is-skyrocketing-toda/
      👍️0
      ElusTrade ElusTrade 2 years ago
      It huge news but no one noticing
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Now UP by a glorious 44%, Peeps & Homeboys!!! Don't miss the FUN -- let alone the PROFITS -- via this MONSTER Medical Science play!!! I guess nobody is YET paying any attention to today's NEWS about this little GEM!!! (HA-HA-HA!!!)

      https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

      https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

      https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Ain't gonna be CRICKETS in here for very much longer, Folks!!!!

      https://www.tipranks.com/news/article/2-insiders-hot-stocks-with-growth-potential/

      https://finance.yahoo.com/news/repare-therapeutics-announces-worldwide-license-200500192.html

      https://seekingalpha.com/news/3844736-rptx-stock-gains-as-roche-signs-licensing-deal-for-tumor-candidate

      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Yet another handy LINK (Fidelity) about this rather NICE news today for RPTX. (HA-HA-HA!!!)
      https://eresearch.fidelity.com/eresearch/evaluate/news/basicNewsStory.jhtml?symbols=RPTX&pageno=&storyid=202206011618RTRSNEWSCOMBINED_FWN2XO0QP_1&provider=RTRSNEWS&product=COMBINED&
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Welcome aboard, Bro!!! This one is the proverbial, "Biggest No-Brainer In The History Of Mankind" routine!!! (Hey, I DO indeed realize that I am iHub's unoffical 'CLASS CLOWN'; but nevertheless, even FOOLS like me can pick-em ONCE in awhile!! HA-HA-HA!!!)


      "Heck, I used to think that the ONLY time in my life that I ever got 'LUCKY', was winning a lousy Two-Dollar-Scratcher for TEN BUCKS in a 7/11-Store back in 1982! But with RPTX, I just hit the MOTHERLODE!!!! Bottom line, finally gettin' some RESPECT!!!!"
      👍️0
      Laszlo1 Laszlo1 2 years ago
      I am in
      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Ya-all MISSED the take-off!! I am already well on my way to the MOON! Never been there, so it may be interesting!

      "This is one small STEP for Mankind; but one GIANT LEAP for the bank account balance of iHub's own JUST-KEEP-TRYING Dude!!!" (HA-HA-HA!!!)

      👍️0
      Just-Keep-Trying Just-Keep-Trying 2 years ago
      RPTX: Anybody gonna join me for a quick trip to the MOON today??? I can fly there all by MYSELF, but it sure gets LONELY way out there; but, I think I can MUSCLE-through-it, nevertheless. (HA-HA-HA!!)

      https://www.marketwatch.com/story/roche-repares-licensing-deal-includes-milestone-payments-worth-up-to-12-billion-2022-06-02

      https://pulse2.com/repare-therapeutics-rptx-stock-price-why-it-increased-over-20-today/

      https://www.postregister.com/businessreport/healthcare/repare-therapeutics-announces-a-worldwide-license-and-collaboration-agreement-with-roche-for-camonsertib-rp-3500/article_a6d38b6f-626d-51f5-a151-9e0e435be816.html

      https://www.marketbeat.com/instant-alerts/nasdaq-rptx-a-buy-or-sell-right-now-2022-06/


      "Heck, last time I saw a stock like THIS rocketship, it landed on Planet JUPITER by lunchtime on Wall Street!"
      👍️0

      Your Recent History

      NASDAQ
      RPTX
      Repare Therapeutics
      NYSE
      SEE
      Sealed Air
      LSE
      FEMI
      Em Qty Us Acc
      LSE
      GSD
      Goldshield
      Delayed Upgrade Clock